Healthcare tablet market to hit $1.7B this year

The global market for tablet PC devices in healthcare is expected to increase to $1.7 billion for 2013, reflecting an increase of nearly 27 percent over the prior year, according to Kalorama Information.   

In a new report, "The Market for Tablet PCs in Healthcare," the healthcare market research publisher said several factors are driving the growth of this market including a shortage of qualified medical professionals, cost restraints, medical error reduction measures, expanding capabilities of devices and off-site medical care.  

Kalorama’s estimate included sales for tablet devices, including hybrid and convertible tablets, where medical professionals or institutions have used these devices for at least 50 percent health-related use. The report says that revenue growth will remain strong. The increasing adoption of tablets in the health industry will drive developers/manufacturers to continue to rollout new, advanced products, securing a healthy market for upgrades and replacement units.

“Tablet PCs are increasingly being used for a variety of tasks in the health field including access to patient records at the point of care, improved viewing capabilities for medical images and easy offsite patient monitoring,” said Melissa Elder, Kalorama analyst and the author of the report.

Viewing radiology images, ordering e-prescriptions and filling out a patient’s electronic record are among the tasks that physicians and other healthcare professionals are using tablet PCs for in a healthcare setting, according to the report.  

The report says that Apple’s iPad has continued to grab a larger share of the market each year, but that there are other competitors interested in the healthcare market, such as Samsung, Research in Motion (BlackBerry), Panasonic, Hewlett Packard, Motion Computing, Lenovo, Fujitsu, Tangent and others, though all are struggling to keep pace with the adoption rate of Apple.   

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?